Is Your Vivitrol Injection Covered? Find Out Now!

Is Your Vivitrol Injection Covered? Find Out Now!

Understanding Vivitrol treatment

What is Vivitrol

Vivitrol is an extended-release formulation of naltrexone approved by the Food and Drug Administration in 2010 for preventing relapse to opioid dependence and treating alcohol dependence. Delivered as a once-monthly injection, it binds to opioid receptors in your brain for up to one month, blocking the effects of opioids and helping to curb cravings. As part of Carolina Energetics’ long acting injectable addiction treatment, Vivitrol supports your path to sustained recovery with a medication option that pairs convenience and clinical evidence.

How Vivitrol works

By occupying opioid receptors, Vivitrol prevents the euphoric and sedative effects of opioid use. This opioid antagonist action reduces the risk of relapse once you have completed detoxification. For best results, Vivitrol is always administered alongside counseling and behavioral therapies that address underlying triggers and strengthen coping skills. Many clients begin with a medically supervised detox and then transition into an outpatient vivitrol maintenance plan where medication management and psychosocial support work hand in hand.

Why insurance matters

Benefits of coverage

Having your Vivitrol injection covered by insurance can:

  • Eliminate or dramatically reduce out-of-pocket costs
  • Ensure consistent monthly dosing without financial interruptions
  • Support adherence, which studies link to better long-term outcomes
  • Remove a major barrier when you’re focused on recovery

Common barriers

Even when plans cover injectable MAT, you may still encounter:

  • Prior authorization requirements
  • Limits on pharmacy versus medical benefit coverage
  • Co-payment or coinsurance obligations
  • Restrictions on prescribing providers or treatment sites

Knowing the details of your policy ahead of time helps you and your care team navigate these hurdles efficiently.

Vivitrol coverage options

Insurance plans overview

Most commercial and government plans now include extended-release naltrexone under their medical or pharmacy benefits. Key statistics show:

  • 99% of people with any insurance, including Medicaid, have Vivitrol coverage[1]
  • Nine out of ten eligible Vivitrol patients pay less than $5 out of pocket per injection†
  • Eligible commercial or uninsured patients may pay as little as $0 per prescription
  • Maximum savings reach up to $500 per injection, capped at 12 injections per calendar year (total savings up to $6,000)
Insurance type Typical copay Notes
Medicaid $4 or less 99% of Medicaid patients pay ≤ $4
Commercial or uninsured $0 – $5 Depends on eligibility in savings program
Maximum savings per dose Up to $500 12 injections per year (max $6,000)
[1]: VIVITROL® Co-pay Savings Program, Vivitrol website.

Medicaid and Medicare details

If you’re covered by Medicaid, extended-release naltrexone is typically included on state formularies, with most enrollees paying $4 or less per injection. Medicare beneficiaries usually obtain Vivitrol under Part D or Part B—verify on your plan’s formulary and ask about prior authorization. Working with a provider experienced in injectable MAT can streamline this process through the insurance verified injectable MAT program.

Explore co-pay savings

Program details

The Vivitrol Co-pay Savings Program helps eligible patients reduce out-of-pocket expenses for each injection. Program highlights include:

  • Up to $500 off per dose, for up to 12 doses per calendar year (maximum $6,000)
  • Reduced costs for commercially insured or self-pay patients, potentially down to $0
  • Medicaid patients automatically pay $4 or less per injection†

†Source: Vivitrol Co-pay Savings Program.

How to apply

  1. Visit the Vivitrol Co-pay Savings page on the official Vivitrol site[2].
  2. Complete the online enrollment form with your insurance details.
  3. Submit any required documentation (proof of insurance or self-pay status).
  4. Receive a savings card or program ID to present at each monthly injection.

Once you have the card, your provider simply applies savings at the time of injection.

[2]: https://www.vivitrol.com/opioid-dependence/verify-insurance-coverage

Verify your coverage

Steps to check coverage

To confirm that your Vivitrol injection is covered by insurance, follow these steps:

  • Contact your insurance company or pharmacy benefits manager
  • Provide the medication code (HCPCS J2315) and dosing frequency (monthly)
  • Ask whether coverage falls under medical or pharmacy benefits
  • Confirm any prior authorization requirements or step-therapy rules
  • Inquire about your exact copay or coinsurance amount

Working with your provider

At Carolina Energetics, our team helps you navigate benefits and prior authorizations. When you enroll in an outpatient vivitrol maintenance plan, our care coordinators will:

  • Verify your coverage details and co-pay obligations
  • Submit necessary authorization requests
  • Schedule monthly visits at our vivitrol program outpatient clinic
  • Offer telehealth follow up to monitor progress[3]
[3]: See vivitrol treatment with telehealth follow up

Compare injectable options

Vivitrol vs Sublocade

Choosing between Vivitrol (extended-release naltrexone) and Sublocade (extended-release buprenorphine) depends on your clinical history and treatment goals. The table below highlights key differences:

Feature Vivitrol Sublocade
Active agent Naltrexone (opioid antagonist) Buprenorphine (partial agonist)
FDA approval 2010 2017
Dosing schedule Once monthly injection Once monthly injection
Mechanism Blocks opioid receptors Activates receptors with ceiling effect
Insurance coverage 99% of plans; low co-pay options Broad coverage; may require PA
Program example Outpatient vivitrol maintenance plan Monthly sublocade treatment program

Deciding which option fits your needs involves a clinical assessment of withdrawal risk, medication interactions, and personal preference.

Counseling integration

Medication alone is rarely sufficient. Both Vivitrol and Sublocade achieve best results when paired with behavioral therapies. Our combined approach includes:

  • Individual and group counseling tailored to your recovery goals
  • Relapse prevention services specific to injectable MAT[4]
  • Integration with sublocade and counseling integration for buprenorphine clients
  • Family education and peer support to strengthen your network
[4]: See vivitrol and relapse prevention services

Plan your next steps

Enroll in a Vivitrol program

To get started:

  1. Schedule an initial assessment with our team—whether you’re in North Carolina or beyond, our vivitrol therapy program north carolina specialists are ready to help.
  2. Verify your insurance benefits and complete any prior authorization.
  3. Begin your monthly injections at our outpatient vivitrol maintenance plan clinic.

Not in North Carolina? You can still find a nearby provider by searching for a sublocade treatment provider near me and asking if they offer Vivitrol.

Find more resources

Staying informed and supported matters. Additional resources include:

  • Funding for recovery housing and sober living programs (SAMHSA awards over $45 million for young adult housing)SAMHSA
  • Comprehensive guides on long acting injectable addiction treatment
  • Research on Vivitrol’s mechanism and efficacy [1]

By confirming your insurance covered Vivitrol injection and enrolling in a coordinated treatment plan, you’re taking a pivotal step toward sustained recovery. Contact Carolina Energetics today to verify your benefits and schedule your first injection.

References

  1. (University of Arkansas for Medical Sciences)

Start Your Healing Journey with Carolina Energetics PC

Ready to begin your path to recovery? Contact us now to schedule a consultation and experience the difference of personalized, professional care in a welcoming environment.

Office Hours
Blood Testing Hours
Urine Testing Hours

Save Buprenorphine

Buprenorphine is under threat—and so are the patients who depend on it.

This life-saving medication is now listed as a “suspicious drug,” leading many pharmacies to stop dispensing it altogether. The DEA is pushing for everyone to switch to Buprenorphine/Naloxone (Suboxone), but not every patient can tolerate Naloxone. Many experience severe side effects or have legitimate sensitivity—even when allergy tests fail to detect it.

We’ve seen firsthand the damage this policy shift is causing.

We need your voice. Congressmen Paul Tonko and Senator Martin Heinrich are sponsoring a bill to protect access to Buprenorphine, and bipartisan support is growing. We urge you to contact your state Senators and President Trump online to support this bill. Your advocacy could help restore patient choice and save lives.

Don’t let politics get in the way of proper care. Help us protect access to Buprenorphine.